Heart Disease :: Trimetazidine an effective antianginal drug

Trimetazidine is an effective antianginal drug that with its minimal side effect profile it has an important role to play when side effects limit haemodynamic agents and in those vulnerable to adverse effects such as one elderly – highlighted in a study conducted by Graham Jackson, Guy’s & St Thomas’ Hospital, Cardiothoracic Centre, St Thomas? Hospital, London, UK

Education :: Television viewing linked with poor school performance among middle school students

A new study links poor school performance among middle school students with television viewing time and content. In “Association Between Television, Movie and Video Game Exposure and School Performance,” researchers surveyed more than 4,500 middle school students (grades 5 through 8) about weekday and weekend television and video screen time, cable channel availability, parental R-movie and television content restriction, and school performance.

Biofuel :: Broin and Novozymes to collaborate on development of ethanol from cellulosic biomass

Two leading players within the growing biofuels industry, Broin and Novozymes, announced a collaboration to take the next steps needed to bring cost-effective ethanol derived from corn stover to market. The collaboration is an extension of the close partnership between the two companies and is a great opportunity for Novozymes to put its unique biotechnology platform at work and for Broin to aim at a fast commercialization.

ADHD :: Daytrana, methylphenidate transdermal system provides individualized ADHD symptom management

Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) announced that its Attention Deficit Hyperactivity Disorder (ADHD) patch, DAYTRANA tm (methylphenidate transdermal system), has significant efficacy in reducing the symptoms of ADHD in children aged 6 to 12 years, even when the ADHD patch is taken off earlier than the recommended nine hours. The ability to remove the patch earlier than the recommended nine-hour wear time allows physicians the opportunity to manage the potential for late-day side effects, such as lack of appetite or difficulty sleeping. These phase IIIb clinical trial results were reported today at a major scientific and educational meeting of child and adolescent psychiatrists in San Diego, Calif.

Exercise :: No time to exercise

Those who maintain that the busy pace of life offers no time to exercise have just run out of another excuse, unless of course they can’t spare three minutes to exercise. The “catch” is that the exercise consists of short bursts of intense effort separated by a few minutes of recovery, meaning a single training session lasts about 20 min. However, a new study published in the Journal of Physiology shows that performing three of those sessions each week provides the same benefits as that achieved by up to two hours of daily moderate exercise.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack